Ranjan Pai

Chairman, Manipal Education & Medical Group; Co-Founder, Aarin Capital; Founder, MEMG Family Office & Claypond Capital at Aarin Capital

Reviewed Updated Jul 1, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Bengaluru, India
Check Size $20M-$300M+ (growth / PIPE), plus early-stage via Aarin Capital
Last Verified Investment InCred Money (Growth (INR 250 Cr)) — Sep 16, 2025
Social LinkedIn
Stage Focus
series-b series-c growth pre-ipo
Sector Focus
healthcare healthtech edtech fintech consumer aviation digital-health

Background

Dr. Ranjan Pai is Chairman of the Manipal Education and Medical Group (MEMG) and one of India’s most active private-capital investors in growth-stage startups. He is the third-generation leader of the Pai family: his grandfather T. M. A. Pai founded Kasturba Medical College in 1953 (India’s first private, self-financed medical college), and his father Ramdas Pai is Chancellor of the Manipal Academy of Higher Education (MAHE) and a 2011 Padma Bhushan awardee 12.

Pai is a medical graduate of Kasturba Medical College, Manipal, and completed a fellowship in hospital administration in the United States 12. He began his career as Managing Director of Melaka Manipal Medical College in Malaysia before founding MEMG in 2000 with an initial $200,000 in capital from a rented house in Bengaluru 1. Under his leadership MEMG has grown to seven universities and twenty-nine hospitals worldwide, with Manipal Hospitals reaching 50+ facilities and 12,500+ beds and ManipalCigna Health Insurance covering 15 million lives 2.

Pai invests through three distinct vehicles:

  1. Aarin Capital (co-founded 2011/2012 with T V Mohandas Pai) — a proprietary venture fund / family-office that has deployed ~$80M across 30+ early-stage startups; Pai has invested $50M of his personal wealth into the fund 3. Aarin is Pai’s earliest and smallest-check vehicle. See the dedicated Aarin Capital profile for the full portfolio.
  2. MEMG Family Office (founded 2016) — Pai’s single-family office; sector-agnostic; has invested ₹3.5 billion (~$420M) across ~20 startups with 20%+ IRR when combined with Aarin 4.
  3. Claypond Capital (launched early 2023) — Pai’s newest family office, structured to deploy $300M+ into startups alongside another $300M reserved for existing MEMG businesses 4.

In April 2023, Singapore’s Temasek acquired a 22% additional stake in Manipal Health Enterprises for a total of $2 billion, valuing the chain at $5 billion and reducing Pai’s stake from 52% to ~30% 5. The transaction generated approximately $1 billion in personal liquidity for Pai, which he has been deploying into Indian growth-stage startups since 4.

As of November 2025 Pai’s net worth was $2.8 billion, ranking him 1305 on the global rich list 1. He is President of MAHE and serves as a jury member of EY Entrepreneur of the Year India 6.

Stated Thesis

Pai’s public messaging emphasizes “confidence capital” for later-stage Indian founders who are executing well but have been misjudged by the market. In a September 2023 Forbes interview he framed his new fund Claypond Capital’s mission this way:

“The founders may have made some mistakes or the external environment may have gone wrong. The point is, can we bring in confidence capital?” 4

He has also publicly described a barbell of personal patience and outsized risk appetite:

“I have a huge tolerance for risk. I don’t know if it is a good thing or a bad thing.” 4

“I always wanted this freedom to invest.” 4

On concentration and long-term ownership, Pai has said:

“Having a 30% to 40% stake in five or six great companies that are well-run and with good corporate governance is plenty enough.” 4

Inferred Thesis

Analysis based on 8 named MEMG / Claypond / personal investments with dated primary-source citations below. Sample is too small to compute reliable sector percentages; qualitative patterns follow.

Vehicle-by-stage split. Pai’s three vehicles carry very different mandates and check sizes:

  • Aarin Capital — seed to Series A, roughly ₹92 lakh to ₹34 Cr per deal (see Aarin Capital firm profile) 7.
  • MEMG Family Office — growth/PIPE, ₹250 Cr to ₹800 Cr per deal in the disclosed rounds below.
  • Claypond Capital — Series B to pre-IPO growth, roughly $20M to $125M-consortium per deal in the disclosed rounds below.

Where Pai personally writes the check (rather than through Aarin), the dominant pattern is large-ticket growth capital into later-stage Indian companies, not seed-stage angel investing.

Sector concentration. Of the 8 named rounds cited below in the Portfolio table: 3 are healthcare/health-tech (PharmEasy, Healthify, ManipalCigna operating investment), 2 are education (Aakash, BYJU’S via Aarin), 1 is fintech (InCred Money), 1 is consumer/e-commerce (FirstCry), 1 is aviation (Akasa Air), and 1 is fintech-adjacent (Easy Home Finance). Healthcare and education — the sectors MEMG operates in directly — remain the biggest single cluster, consistent with domain expertise. Aviation (Akasa) is the notable outlier.

Distinctive pattern: distressed-asset / turnaround appetite. Two of Pai’s largest post-2022 investments were in companies in distress:

  • Aakash Educational Services — Pai acquired ₹1,400 Cr of Byju’s debt (secured against Aakash shares) in November 2023, then converted a $300M investment into equity in January 2024 for a 40% stake, becoming the single largest shareholder; the deal made Aakash debt-free 89.
  • PharmEasy (API Holdings) — MEMG led a $216M “confidence” round in April 2024 at a $710M valuation, down ~90% from PharmEasy’s $5.6B peak; MEMG’s portion was ₹800 Cr (~$96M), giving Pai a ~12% stake 10.

This is the “confidence capital” thesis in action: Pai is willing to underwrite companies whose external-market valuation has collapsed but whose underlying business he judges viable.

Co-investor patterns. Repeat co-investors in named rounds include Premji Invest (Akasa Air 2025-02, and separately overlapping in growth Indian companies), Temasek (PharmEasy April 2024; also Manipal Hospitals majority owner from April 2023), Khosla Ventures / LeapFrog (Healthify October 2024), Mankind Family Office (InCred Money September 2025), and 360 ONE Asset / PortfoliOne (PharmEasy and Akasa Air). The recurring pattern is Indian family offices + Temasek/Premji-scale strategics.

Geographic focus. Overwhelmingly India-centric. Healthify’s U.S. expansion is the notable outward-looking exception.

Founder pedigree pattern. PrivateCircle analysis of the MEMG Family Office portfolio (46 founders tracked) found ~30% attended IITs (14 of 46), with the remainder from NITs and state institutions 11. This is meaningfully higher than the Aarin Capital sample (which skews non-IIT/IIM) — suggesting Pai’s later-stage vehicles gravitate toward more heavily-credentialed founding teams than his earliest-stage vehicle does.

Portfolio

Portfolio below is limited to rounds where Ranjan Pai personally, MEMG Family Office, or Claypond Capital was named in a primary press source. Aarin Capital investments (BYJU’S 2012, TripFactory, KleverKid, 88academics, etc.) are tracked in the Aarin Capital firm profile.

Company Year Stage Source
BYJU’S 2013 Early (₹50 Cr, ~26% stake via Aarin Capital) Forbes India, 2017 3
ManipalCigna Health Insurance 2016+ Operating investment (₹850 Cr committed) Forbes 2023 4
PharmEasy (API Holdings) 2024-04-30 Growth PIPE (₹800 Cr of $216M round; MEMG lead) PressInsider 10
FirstCry 2023-08 Pre-IPO secondary (₹250 Cr) Forbes 2023 4
Aakash Educational Services 2024-01 (converted from 2023-11 debt) Debt-to-equity, $300M for 40% stake Business Standard, Indianstartupnews 89
Easy Home Finance 2024-11-06 Series B ($35M, Claypond led) Indianstartupnews 12
Healthify (HealthifyMe) 2024-10-25 Growth ($20M new capital in $45M round; Claypond participated) LeapFrog press release 13
Akasa Air 2025-02-06 Growth (~$125M consortium with Premji Invest / 360 ONE; Claypond participated) Akasa Air press release 14
InCred Money 2025-09-16 Growth (₹250 Cr at ₹1,650 Cr valuation; Pai co-invested with Mankind Family Office, Ram Nayak) Inc42 15

Aggregator profiles list additional companies (BlueStone, Finnable, Zolo, Impact Analytics, Thinkster Math, HomeLane, Fabhotels) as Ranjan Pai investments, but these could not be independently verified against a primary source in this research pass and are excluded rather than guessed 1617.

In Their Own Words

Pai on his risk profile and freedom to invest:

“I always wanted this freedom to invest… I have a huge tolerance for risk. I don’t know if it is a good thing or a bad thing.” — Ranjan Pai, Forbes interview, September 7, 2023 4

On the “confidence capital” thesis that motivates Claypond Capital:

“The founders may have made some mistakes or the external environment may have gone wrong. The point is, can we bring in confidence capital?” — Ranjan Pai, Forbes, September 7, 2023 4

On concentration:

“Having a 30% to 40% stake in five or six great companies that are well-run and with good corporate governance is plenty enough.” — Ranjan Pai, Forbes, September 7, 2023 4

On the Temasek deal and continuing to invest in healthcare rather than exit:

“I don’t want people to assume that I am exiting healthcare. Obviously we did take some money off the table. But I am not going to sell down any more. And I will continue to invest to maintain my stake.” — Ranjan Pai, Forbes, September 7, 2023 4

On startup-investing lessons:

“An entrepreneur does not have to go to the investor who writes the biggest cheque, or gives the highest valuation.” — Ranjan Pai, Forbes India, 2017 3

“I have picked up my own investment strategy from my investors.” — Ranjan Pai, Forbes India, 2017 3

On MEMG’s geographic-selection criteria (from an Outlook Business profile):

“We look at geography. Mostly, Tier–I and –II cities are good for us. We have an internal map of cities we like.” — Ranjan Pai, Outlook Business 18

On Claypond Capital’s Healthify investment:

“AI has the potential to exponentially improve health outcomes. Healthify has proven that in India at scale and I wish them all the best as they go global.” — Dr. Ranjan Pai, Claypond Capital, October 25, 2024 13

What Founders Say

K Ganesh — serial entrepreneur and founder of TutorVista (a Pai-backed company via Aarin/personal investment) — on why Pai is a valuable investor to have on the cap table:

“He’s an entrepreneur running a large enterprise… that makes him a great investor to have on your side. He is very entrepreneur friendly… you don’t take 100 percent off the table.” — K Ganesh, quoted in Forbes India, 2017 3

Rohit Chokhani, Managing Director of Easy Home Finance, on the November 2024 Series B led by Claypond Capital:

“The fundraise will be used for our asset book building, aiming to reach approximately $300 million in assets in the next 24 months.” — Rohit Chokhani, Easy Home Finance, November 6, 2024 12

The Chokhani quote is a standard capital-use statement rather than a testimonial about the working relationship with Claypond; the Ganesh quote is the only substantive founder-experience quote located in this research pass. Additional founder testimonials specifically about Pai as an investor were not independently sourced.

Connections

  • Co-founder, Aarin Capital (2011/2012) — with T V Mohandas Pai (former Infosys CFO, no family relation) 37
  • Chairman, Manipal Education & Medical Group — reports to a board that includes Temasek-nominated directors following the April 2023 majority-stake acquisition 5
  • Board member, Aakash Educational Services — as largest shareholder (40% stake) following January 2024 equity conversion 8
  • President, Manipal Academy of Higher Education (MAHE) — Institute of Eminence, Government of India 2
  • Jury member, EY Entrepreneur of the Year India 6

Sources

  1. Wikipedia, “Ranjan Pai,” accessed July 2026. https://en.wikipedia.org/wiki/Ranjan_Pai↩↩↩↩

  2. Manipal Group, “Leadership,” accessed July 2026. https://manipalgroup.com/leadership/↩↩↩↩

  3. Forbes India, “Ranjan Pai: The Benevolent Investor,” 2017. https://www.forbesindia.com/article/startups/ranjan-pai-the-benevolent-investor/47527/↩↩↩↩↩↩

  4. Forbes, “Indian Billionaire Ranjan Pai Is Looking To Cement His Legacy With A Billion-Dollar Windfall,” Anu Raghunathan, September 7, 2023. https://www.forbes.com/sites/anuraghunathan/2023/09/07/indian-billionaire-ranjan-pai-is-looking-to-cement-his-legacy-with-a-billion-dollar-windfall-is-a-calculated-bet-to-fund-troubled-startups-the-first-step/↩↩↩↩↩↩↩↩↩↩↩↩↩

  5. BW Healthcare World, “Singapore’s Temasek Acquires Majority Stake In Manipal Hospitals For $2 Billion,” accessed July 2026. https://www.bwhealthcareworld.com/article/singapores-temasek-acquires-majority-stake-in-manipal-hospitals-for-2-billion-472147↩↩

  6. EY India, “Ranjan Pai – Chairman, Manipal Education and Medical Group | Jury,” accessed July 2026. https://www.ey.com/en_in/entrepreneur-of-the-year/jury/ranjan-pai↩↩

  7. Aarin Capital, “About,” accessed July 2026. https://aarincapital.com/about/↩↩

  8. Business Standard, “Ranjan Pai to own 40% in Byju’s Aakash Institute, make it debt-free,” January 25, 2024. https://www.business-standard.com/companies/news/ranjan-pai-to-own-40-in-byju-s-aakash-institute-make-it-debt-free-124012500186_1.html↩↩↩

  9. Indian Startup News, “Ranjan Pai-led Manipal Group gets CCI approval to acquire stake in Byju’s-owned Aakash Institute,” July 25, 2024. https://indianstartupnews.com/news/ranjan-pai-led-manipal-group-gets-cci-approval-to-acquire-stake-in-byjus-owned-aakash-institute-6697069↩↩

  10. PressInsider, “Ranjan Pai’s MEMG leads $216 million funding in PharmEasy,” April 30, 2024. https://pressinsider.com/business/ranjan-pais-memg-leads-216-million-funding-in-pharmeasy/↩↩

  11. PrivateCircle Blog, “MEMG Family Office 2024 Report: Top Investments and Revenue,” accessed July 2026. https://blog.privatecircle.co/memg-family-offices-portfolio-overview-2024/↩

  12. Indian Startup News, “Easy Home Finance raises $35 million in funding led by Ranjan Pai’s Claypond Capital,” November 6, 2024. https://indianstartupnews.com/funding/easy-home-finance-raises-usd-35-million-in-funding-led-by-ranjan-pai-claypond-capital-755024↩↩

  13. LeapFrog Investments, “Healthify raises $20M in fresh capital to drive US expansion,” October 25, 2024. https://leapfroginvest.com/press-release/healthify-raises-20m-in-fresh-capital-to-drive-us-expansion/↩↩

  14. Akasa Air press release, “Akasa Air welcomes strategic investment partners, solidifying its long-term growth,” February 6, 2025. https://www.akasaair.com/news-room/akasa-press-releases/akasa-air-welcomes-strategic-investment-partners-solidifying-its-long-term-growth↩

  15. Inc42, “InCred Money Raises INR 250 Cr At INR 1,650 Cr Valuation,” September 16, 2025. https://inc42.com/buzz/incred-money-raises-inr-250-cr-at-inr-1650-cr-valuation/↩

  16. Tracxn, “Ranjan Pai - 2026 Portfolio & Founded Companies,” accessed July 2026. https://tracxn.com/d/people/ranjan-pai/__bvjUzq2l85wryyREy_yY-EiFtv9tfdNb5DgJxRd5USQ↩

  17. CB Insights, “Ranjan Pai Portfolio Investments, Funds, Exits,” accessed July 2026. https://www.cbinsights.com/investor/ranjan-pai↩

  18. Outlook Business, “Ranjan Pai Creates a Capitalism of Care to Make Manipal the Largest Hospital Chain in India,” accessed July 2026. https://www.outlookbusiness.com/magazine/ranjan-pai-creates-a-capitalism-of-care-to-make-manipal-the-largest-hospital-chain-in-india↩